Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Epioxa™ HD/Epioxa™ and UV-A Irradiation | Experimental | Epioxa™ HD/Epioxa™ and UV-A Irradiation using the O2n™ System and Supplemental Oxygen using the Boost Goggles® |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Riboflavin Ophthalmic Solutions | Drug | Riboflavin Ophthalmic Solutions |
|
| Measure | Description | Time Frame |
|---|---|---|
| Successful completion of bilateral epithelium-on corneal collagen cross-linking. | Portion of subjects that the Investigator completed bilateral epithelium-on corneal collagen cross-linking treatment on the same day. | Approximately 2.5 Months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Study Director | Contact | 949-739-8749 | ClinicalResearch@glaukos.com |
| Name | Affiliation | Role |
|---|---|---|
| Study Director | Glaukos Corporation | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Glaukos Investigative Site | Recruiting | Westerville | Ohio | 43082 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007640 | Keratoconus |
| ID | Term |
|---|---|
| D003316 | Corneal Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UV-A Irradiation System | Device | O2n UV-A Irradiation System |
|